Advertisement

VEGF Mab rDNA - Biotech, Pharma and Life Science Channel

14:36 EDT 24th May 2013 | BioPortfolio

PubMed Articles [ 20600 Associated PubMed Articles listed on BioPortfolio]

Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone.

Giant cell tumor (GCT) of bone is a benign but locally aggressive neoplasm of bone. However, molecular mechanisms underlying osteolysis in GCT have not been deeply understood. The aim of this study wa...

The prognostic value of platelet endothelial cell adhesion molecule-1 in non-small-cell lung cancer patients.

Our previous studies have shown that platelet endothelial cell adhesion molecule-1 (PECAM-1), a member of the immunoglobulin superfamily, is a critical mediator of anchorage-independent growth and ano...

Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.

The anti-VEGF monoclonal antibody bevacizumab was approved in 2004 as a first-line treatment for metastatic colorectal cancer (CRC) in combination with chemotherapy and provided proof of principle for...

Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion.

Hepatoma-derived growth factor (HDGF), a heparin-binding growth factor, has a wide range of biological functions, including mitogenic activity and vascular development. Recent studies demonstrated tha...

PTPN4 negatively regulates CrkI in human cell lines.

PTPN4 is a widely expressed non-receptor protein tyrosine phosphatase. Although its overexpression inhibits cell growth, the proteins with which it interacts to regulate cell growth are unknown. In th...

New data on Longidorus aetnaeus Roca, Lamberti, Agostinelli & Vinciguerra, 1986 (Nematoda: Longidoridae) from Iran and Ajaria (Georgia).

Longidorus aetnaeus Roca, Lamberti, Agostinelli & Vinciguerra, 1986 is reported for the first time from Iran and Ajaria (Georgia). Morphological and morphometric data are provided for two Iranian and...

Morphological and molecular characterisation of Xiphinema macroacanthum Lamberti, Roca & Agostinelli, 1989 (Nematoda: Longidoridae) from olive orchards in southern Italy.

A population of Xiphinema macroacanthum Lamberti, Roca & Agostinelli, 1989 originating from olive orchards in Brindisi, Italy and containing both adults and all juvenile stages, is described and illus...

Sub-2 nm size and density tunable platinum nanoparticles using room temperature tilted-target sputtering.

This paper describes a tilted-target RF magnetron sputter deposition system to grow nanoparticles in a controlled way. With detailed characterization of ultra-high density (up to 1.1 × 10(13) cm(-...

Structure of the O-antigen of a novel Shigella flexneri serotype, 1d (I: 7,8).

Recently, strains of a novel Shigella flexneri serotype called 1d have been isolated from diarrheal patients in China. They are distinguished by the presence of a hitherto unknown combination of type...

Simultaneous increase in electrical conductivity and Seebeck coefficient in highly boron-doped nanocrystalline Si.

A large thermoelectric power factor in heavily boron-doped p-type nanograined Si with grain sizes ∼30 nm and grain boundary regions of ∼2 nm is reported. The reported power factor is ∼5 times...

News Articles [ 7945 Associated News Articles listed on BioPortfolio]

BRIC nations "not delivering high-growth healthcare promise"

BRIC nations "not delivering high-growth healthcare promise"

Dividend Growth Gem Medtronic Is A Cash Cow

By Valuentum: Dividend Growth Newsletter holding Medtronic (MDT) reported wonderful fourth quarter results. Revenue grew 4% on a reported basis (5% ex-currency) to $4.5 billion, easily exceeding conse...

West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough

Pittsburgh, PA (PRWEB) May 24, 2013 Patients who have chronic cough with no known cause may be more likely to suffer from gastroesophageal reflux disease or GERD, West Penn Allegheny Health System...

EGFR gums up cell's miRNA-processing machinery under oxygen starvation conditions

Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs before it's...

Pfizer Has Potential To Grow Despite Decreasing Sales

ByAlpha Hunter:Pfizer (PFE) is the world's largest research-based pharmaceutical company. It discovers, manufactures and leads the global market in prescription drugs and healthcare products. The comp...

New data reinforces clinical importance of independent Alzheimer’s risk factor

Manchester, Birmingham & Oxford, UK May 2013 – Cytox Limited, a UK company developing diagnostic and prognostic services for Alzheimer’s disease, announces the publication of new data using its...

Obstructive Sleep Apnea Associated With Abdominal Fat Accumulation In Men

A new study from researchers in Japan indicates that obstructive sleep apnea (OSA) is independently associated with visceral (abdominal) fat accumulation only in men, perhaps explaining gender differe...

LPL Financial to Present at the William Blair 33rd Annual Growth Stock Conference

BOSTON, May 24, 2013 (GLOBE NEWSWIRE) -- LPL Financial Holdings Inc. (Nasdaq:LPLA) (the "Company"), parent company of LPL Financial LLC ("LPL Financial"), announced today that Mark Casady, chairman a...

Announcements in Conjunction With Theratechnologies Annual Meeting

MONTREAL, CANADA -- (Marketwired) -- 05/24/13 -- Theratechnologies Inc. (TSX: TH) today held its annual meeting of shareholders, chaired by Paul Pommier, chairman of the board of Theratechnologies....

Genetic Risk Factor Discovered For Pulmonary Fibrosis

A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk fact...

Events [ 3 Associated Events listed on BioPortfolio]

Payer Strategies for Emerging Markets

Understand payer needs, build robust partnerships and drive profit growth.

Diabetes: Secondary Complications, Regulation and Innovation Conference

SMi is very proud to present our 11th conference focusing on Diabetes and metabolic disorders taking place on 1st and 2nd Oct 2013, London.

Ribosomes Napa Valley Conference 2013

Protein synthesis by the ribosome plays a central role in connecting genotypes to phenotypes in biology.

Companies [ 254 Associated Companies listed on BioPortfolio]

Pamlab

Deplin is a prescription medical food for the dietary management of suboptimal L-methylfolate levels in patients with depression. Up to 70 percent of people who suffer from depression may have a spec...

Stentys

Based in Princeton, N.J., and Paris, Stentys has developed a new generation of stents for the treatment of acute myocardial infarction. Founded by Jacques Séguin, M.D., Ph.D.,...

Cerapedics, Inc.

Cerapedics is a privately-held medical device company focused on developing and commercializing novel osteobiologic products based on its proprietary anorganic bone mineral (ABM)...

IRI Consulting

IRI Consulting provides strategic insights and actionable recommendations to leverage growth with support from IRI’s proprietary, granular data, analytics and technology asse...

BIO and ABFA and ABO and A4A and AFBF and Growth Energy and Pew Charitable Trusts

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 o...

RXi Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation (OTC: RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi plat...

BioNova - The Nova Scotia Biotechnology and Life Sciences Industry Association

BioNova was incorporated in 1993 in response to rapid growth in Nova Scotia’s biotechnology and life sciences sector. Since that time, we have advanced alongside our members to offer advocacy and de...

BIOTRONIK

BIOTRONIK® is a leading European company in the field of biomedical technology. Our main focus is on the business sectors of electrotherapy of the heart and vascular intervention. Our products help p...

GfK Group

The GfK Group (GfK = Growth from Knowledge) is a well-respected member of the global market research industry. Established more than 70 years ago, originally as the non-profit "Association for Consume...

Cellmid Limited

Cellmid is an Australian biotechnology company developing innovative novel therapies and diagnostic tests for inflammatory diseases, heart attack and cancer. Cellmid holds the lar...

Clinical Trials [ 3703 Associated Clinical Trials listed on BioPortfolio]

Pamidronate to Treat Osteogenesis Imperfecta in Children

This study will evaluate the effect of pamidronate-a drug that decreases bone resorption (breakdown)-on osteogenesis imperfecta. This is a genetic disorder of collagen, the major protein...

Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1

This study will evaluate the safety and effectiveness of insulin-like growth factor-1 (IGF-1) to treat patients with X-linked severe combined immunodeficiency (XSCID). Those who have XSCID...

Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

RATIONALE: Dutasteride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well dutasteride works in tr...

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

This phase I trial is studying the side effects and best dose of vorinostat and gemcitabine in treating patients with metastatic or unresectable solid tumors. Drugs used in chemotherapy, s...

Exercise and Metformin in Colorectal and Breast Cancer Survivors

Metformin is a medication that is commonly used in the treatment of diabetes. Recently small studies in cancer patients without diabetes suggest that metformin may benefit in lowering ins...

A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A

This trial is conducted globally. The aim of the trial is to investigate safety, efficacy and pharmacokinetics (the exposure of the trial drug in the body) of NNC 0129-0000-1003 (N8-GP) in...

Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer

Tipifarnib may stop the growth of breast cancer by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Drugs used in chemotherapy, such as paclitax...

Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib

RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well dasatinib works in treati...

Usefulness of Myocardial Deformation Imaging for Trastuzumab-induced Cardiotoxicity

Trastuzumab prolongs survival in patients with human epidermal growth factor receptor type 2-positive breast cancer. Sequential left ventricular (LV) ejection fraction (EF) assessment has...

Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

This phase I trial is studying the side effects and the best dose of selumetinib in treating young patients with recurrent or refractory low grade glioma. Selumetinib may stop the growth o...

Videos

None Available

Medical and Biotech [MESH] Definitions

Thrombopoiesis

The process of generating thrombocytes (BLOOD PLATELETS) from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via the MEGAKARYOCYTES. The humoral factor with thrombopoiesis-stimulating activity is designated THROMBOPOIETIN.

Host Factor 1 Protein

An integration host factor that was originally identified as a bacterial protein required for the integration of bacteriophage Q beta (ALLOLEVIVIRUS). Its cellular function may be to regulate mRNA stability and processing in that it binds tightly to poly(A) RNA and interferes with ribosome binding.

Factor For Inversion Stimulation Protein

A highly abundant DNA binding protein whose expression is strongly correlated with the growth phase of bacteria. The protein plays a role in regulating DNA topology and activation of RIBOSOMAL RNA transcription. It was originally identified as a factor required for inversion stimulation by the Hin recombinase of SALMONELLA and Gin site-specific recombinase of BACTERIOPHAGE MU.

Tata-box Binding Protein

A general transcription factor that plays a major role in the activation of eukaryotic genes transcribed by RNA POLYMERASES. It binds specifically to the TATA BOX promoter element, which lies close to the position of transcription initiation in RNA transcribed by RNA POLYMERASE II. Although considered a principal component of TRANSCRIPTION FACTOR TFIID it also takes part in general transcription factor complexes involved in RNA POLYMERASE I and RNA POLYMERASE III transcription.

Transcription Factor Tfiiib

One of several general transcription factors that are specific for RNA POLYMERASE III. TFIIIB recruits and positions pol III over the initiation site and remains stably bound to the DNA through multiple rounds of re-initiation by RNA POLYMERASE III.

Search BioPortfolio:
Advertisement
review and buy VEGF Mab rDNA market research data and corporate reports here

Channels Quicklinks

Advertisement